Century Therapeutics Inc Capital Reinvestment Ratio
Century Therapeutics Inc capital reinvestment ratio. Century Therapeutics Inc (IPSC) has a Capital Reinvestment Ratio of 0.05x as of March 2022, meaning it reinvests 0% of its operating cash flow ($86.75 Million) in capital expenditures ($4.07 Million). Check Century Therapeutics Inc (IPSC) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Century Therapeutics Inc (2015–2022)
Capital reinvestment ratio of Century Therapeutics Inc from 2015 to 2022. This chart tracks Century Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore net asset growth rate of Century Therapeutics Inc to track the company's year-over-year net asset growth rate.
Century Therapeutics Inc Capital Reinvestment Ratio by Year (2015–2022)
Century Therapeutics Inc capital reinvestment ratio by year from 2015 to 2022. For the full cash flow conversion analysis, see Century Therapeutics Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.18x | $14.05 Million | $30.60 Million | ▲ +672.7% |
| 2015 | 0.28x | $104.30 Million | $29.39 Million | — |